Commentary: Stentless AVR in dialysis patients – another hand on the elephant

      Increasing durability of tissue valves make them an attractive option in the hemodialysis population.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Malik A.
        • Longi F.
        • Naeem A.
        • et al.
        Outcomes in patients with chronic renal failure on hemodialysis after aortic valve or root replacement.
        Semin Thor Cardiovasc Surg. 2022; 34: 880-888
        • Yerokin B.A.
        • Vallabhajoosyula P.
        • Vekstein A.M.
        • et al.
        Long term outcomes of aortic root operations in the United States among Medicare beneficiaries.
        JTCVS. 2021; ((online ahead of print PMID33814173)
        • Englum B.R.
        • Pavlisko E.N.
        • Mack M.C.
        • et al.
        Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation; a word of caution.
        Ann Thorac Surg. 2014; 98: 2061-2067
        • Johnston D.R.
        • Griffith B.P.
        • Puskas J.D.
        • Bavaria J.E.
        • Svensson L.G.
        Commence Trial Investigators. JTCVS. 2020; (online ahead of print) PMID32340804)

      Linked Article

      • Outcomes in Patients With Chronic Renal Failure on Hemodialysis After Aortic Valve or Root Replacement
        Seminars in Thoracic and Cardiovascular SurgeryVol. 34Issue 3
        • Preview
          The long-term survival and reoperation rate in chronic renal failure (CRF) on hemodialysis (HD) patients after aortic valve/root replacement (AVR/ARR) with a stentless bioprosthesis is unknown. From 1992–2015, 1941 patients underwent AVR/ARR with stentless valve for primary indications of aortic stenosis/insufficiency, root aneurysm, and acute type A aortic dissection, including 93 CRF-HD (64 new-onset postoperative HD, and 29 preoperative HD) and 1848 non-CRF-HD. Data was obtained from the STS database, retrospective chart review, administered surveys and national death index data.
        • Full-Text
        • PDF